Free Access
Med Sci (Paris)
Volume 30, Number 12, Décembre 2014
Page(s) 1066 - 1069
Section Nouvelles
Published online 24 December 2014
  1. Cohen-Tannoudji M, Guénet JL. Une nouvelle ère pour la génétique du rat. Med Sci (Paris) 2011 ; 27 : 387–390. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Dupret B, Angrand PO. L’ingénierie des génomes par les TALEN. Med Sci (Paris) 2014 ; 30 : 186–193. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. R. Barrangou. Cas9 targeting and the CRIPSR révolution. Science 2014 ; 344 : 707–708. [CrossRef] [PubMed] [Google Scholar]
  4. Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012 ; 337 : 816–821. [CrossRef] [PubMed] [Google Scholar]
  5. Le Cong, Ran FA, Cox D, et al. Multiplex génome engineering using CRISPR/Cas systems. Science 2013 ; 339 : 819–823. [CrossRef] [PubMed] [Google Scholar]
  6. Mali P, Yang L, Esvelt KM, et al. RNA-guided human génome engineering via Cas9. Science 2013 ; 339 : 823–826. [CrossRef] [PubMed] [Google Scholar]
  7. Shalem O, Sanjana NE, Hartenian E, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014 ; 343 : 84–87. [CrossRef] [PubMed] [Google Scholar]
  8. Deltcheva E, Chylinski K, Sharma CM, et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 2011 ; 471: 602–607. [CrossRef] [PubMed] [Google Scholar]
  9. Sternberg SH, Redding S, Jinek M, Greene EC, Doudna JA. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 2014 ; 507 : 62–67. [CrossRef] [PubMed] [Google Scholar]
  10. Ding Q, Regan SN, Xia Y, et al. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 2013 ; 12 : 393–394. [CrossRef] [PubMed] [Google Scholar]
  11. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014 ; 157 : 12162–12178. [Google Scholar]
  12. Niu Y, Shen B, Cui Y, et al. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 2014 ; 156 : 836–843. [CrossRef] [PubMed] [Google Scholar]
  13. Xue W, Chen S, Yin H, et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 2014 ; 514 : 380–384. [CrossRef] [PubMed] [Google Scholar]
  14. Wu Y, Liang D, Wang Y, et al. Correction of a genetic disease in a mouse via use of CRISPR-Cas9. Cell Stem Cell 2013 ; 13 : 659–662. [CrossRef] [PubMed] [Google Scholar]
  15. Schwank G, Koo BK, Sasselli V, et al. Functional Repair of CFTR by CRISPR/Cas9. Cell Stem Cell 2013 ; 13 : 653–658. [CrossRef] [PubMed] [Google Scholar]
  16. Chen B, Gilbert LA, Cimini BA, et al. Dynamic imagingof genomic loci inliving human cellz by an optimized CRISPR/Cas system. Cell 2013 ; 155 : 1479–1491. [CrossRef] [PubMed] [Google Scholar]
  17. Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera C, Yusa K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 2014 ; 32 : 267–273. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.